Lipid Lowering Medication

DRUG3 trials

Sponsors

Grace Therapeutics Inc., Shanghai Zhongshan Hospital, University of Colorado, Denver

Conditions

Acute Myocardial Infarction (AMI)CardiovascularHypertriglyceridemiaMenopauseMenopause Hot FlashesMenopause Related ConditionsMultivessel Coronary Artery Disease

Phase 2

Assess the Safety and Efficacy of NKPL66 (CaPre™) in the Treatment of Mild-to-high Hypertriglyceridemia

CompletedNCT01516151

Grace Therapeutics Inc.Hypertriglyceridemia

Start: 2011-12-31End: 2013-09-30Updated: 2014-01-08

Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

Not yet recruitingNCT06975111

University of Colorado, DenverCardiovascular, Menopause, Menopause Hot Flashes +1

Start: 2026-03-01End: 2030-10-01Target: 200Updated: 2026-03-09

Unknown Phase

Evolocumab in Patients With Multivessel Coronary Disease After Acute Myocardial Infarction: A Target Trial Emulation

CompletedNCT06740552

Shanghai Zhongshan HospitalAcute Myocardial Infarction (AMI), Multivessel Coronary Artery Disease

Start: 2021-01-01End: 2025-10-31Updated: 2026-02-02

Related Papers

Left atrial appendage occlusion study III-Kidney substudy.

2025-04-19

Effectiveness of a Novel ω-3 Krill Oil Agent in Patients With Severe Hypertriglyceridemia

JAMA Network Open2022-01-0622 citations